These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 6096896

  • 1. Possible noradrenergic involvement in naloxone potentiation of apomorphine-induced stereotypic climbing in mice.
    Quock RM, Bloom AS, Sadowski JA.
    Pharmacol Biochem Behav; 1984 Nov; 21(5):733-6. PubMed ID: 6096896
    [Abstract] [Full Text] [Related]

  • 2. Naloxone potentiation of apomorphine-induced stereotypic climbing in mice and interaction with mu-, sigma- and kappa-opiate drugs.
    Quock RM.
    Life Sci; 1982 Dec 20; 31(25):2907-11. PubMed ID: 6298534
    [No Abstract] [Full Text] [Related]

  • 3. Potentiation of apomorphine-induced stereotypies by naloxone and L-prolyl-L-leucyl-glycinamide.
    Quock RM, Lucas TS, Hartl TJ.
    Pharmacol Biochem Behav; 1983 Jul 20; 19(1):49-52. PubMed ID: 6137836
    [Abstract] [Full Text] [Related]

  • 4. Narcotic antagonist potentiation of apomorphine drug effect: a stereospecific, centrally mediated drug action.
    Quock RM, Kouchich FJ, Fries DS.
    Prog Neuropsychopharmacol Biol Psychiatry; 1985 Jul 20; 9(3):239-43. PubMed ID: 4041065
    [Abstract] [Full Text] [Related]

  • 5. Potentiation of apomorphine-induced stereotyped behaviour by acute treatment with dopamine depleting agents: a potential role for an increased stimulation of D1 dopamine receptors.
    Vasse M, Protais P.
    Neuropharmacology; 1989 Sep 20; 28(9):931-9. PubMed ID: 2554186
    [Abstract] [Full Text] [Related]

  • 6. Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in mice.
    Kovács GL, Szabó G, Penke B, Telegdy G.
    Eur J Pharmacol; 1981 Jan 29; 69(3):313-9. PubMed ID: 6260512
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the dopaminergic effects of apomorphine and (-)-N-n-propylnorapomorphine.
    Menon MK, Clark WG, Neumeyer JL.
    Eur J Pharmacol; 1978 Nov 01; 52(1):1-9. PubMed ID: 569056
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Microwave facilitation of domperidone antagonism of apomorphine-induced stereotypic climbing in mice.
    Quock RM, Kouchich FJ, Ishii TK, Lange DG.
    Bioelectromagnetics; 1987 Nov 01; 8(1):45-55. PubMed ID: 3579999
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of age on behavioral responses to dopamine agonists in the rat.
    Ushijima I, Mizuki Y, Soeda K, Kishimoto O, Hara T, Yamada M.
    Eur J Pharmacol; 1987 Jun 12; 138(1):101-6. PubMed ID: 2887433
    [Abstract] [Full Text] [Related]

  • 18. Effects of thymoleptics on behavior associated with changes in brain dopamine. II. Modification and potentiation of apomorphine-induced stimulation of mice.
    Molander L, Randrup A.
    Psychopharmacology (Berl); 1976 Sep 17; 49(2):139-44. PubMed ID: 825900
    [Abstract] [Full Text] [Related]

  • 19. Phencyclidine-induced stereotype in rats: effects of methadone, apomorphine, and naloxone.
    Verebey K, Kogan MJ, Mulè SJ.
    Psychopharmacology (Berl); 1981 Sep 17; 75(1):44-7. PubMed ID: 6795658
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.